Hutch News
New data on cancer disparities in Washington
Health equity, patient voices and patient-engaged research hot topics at Value in Cancer Care Summit
How to boost cancer clinical trial participation
New study suggests loosening strict comorbidity criteria would open trials to thousands of previously exempt patients
Dr. James Dai receives $2.1M NCI grant for cancer biomarker research
Biostatistician plans to use funds to develop statistical models to further precision cancer prevention and treatment
Closing the rural-urban cancer survival gap
‘Guideline care’ in clinical trials erased cancer death-rate disparities
Dr. Yingqi Zhao receives SWOG Coltman Fellowship early-career award
She plans to use the funds to develop new surveillance and diagnostic strategies for immunotherapy trials
Acupuncture can curb AI-induced joint pain in some breast cancer patients
Large, randomized trial shows integrative approach relieves common side effect of estrogen-suppressing drug
Cardiovascular disease competes with breast cancer
From the Unger Group, Public Health Sciences Division
Finasteride can reduce prostate cancer risk long term
Fred Hutch study taps big data to tease out extended cancer-prevention benefit of drug used for enlarged prostate, hair loss
Matching up cancer risk with reality
New examination of prostate cancer data identifies ‘detection bias’ in prostate studies
Good News: Global Oncology wins NCI grant; 1100 Eastlake building honored; Bish Paul essay in Science; Dr. Joseph Unger leads finasteride study
Celebrating faculty and staff achievements
Improving survival and reducing side effects in Hodgkin lymphoma
New data from cooperative trial suggest PET imaging could guide treatment
Cancer clinical trials: In defense of the negative result
Large cancer clinical trials that ‘fail’ carry just as much scientific oomph as positive findings, new study shows
Good News at Fred Hutch
Celebrating faculty and staff achievements
New hope for preserving fertility during breast cancer treatment
A medication that temporarily shuts down ovaries may offer women another option, new research shows
Vitamin E, selenium linked to increased prostate cancer risk
New Fred Hutch study raises caution about high doses of supplements
Selenium and vitamin E supplements can increase risk of prostate cancer in some men - Fred Hutchinson Cancer Research Center
Vitamin E can heighten the risk in men with low baseline selenium levels; selenium supplements can raise the risk in men with high baseline levels of the trace element
Ostronoff, Shankaran win two-year SWOG research grants
Fred Hutchinson Cancer Research Center investigators are among three recipients of $100,000 Coltman Fellowships from SWOG, formerly known as the Southwest Oncology Group
